{
  "address1": "333 Lakeside Drive",
  "city": "Foster City",
  "state": "CA",
  "zip": "94404",
  "country": "United States",
  "phone": "650 574 3000",
  "fax": "650 578 9264",
  "website": "https://www.gilead.com",
  "industry": "Drug Manufacturers - General",
  "industryKey": "drug-manufacturers-general",
  "industryDisp": "Drug Manufacturers - General",
  "sector": "Healthcare",
  "sectorKey": "healthcare",
  "sectorDisp": "Healthcare",
  "longBusinessSummary": "Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.",
  "fullTimeEmployees": 17600,
  "companyOfficers": [
    {
      "maxAge": 1,
      "name": "Mr. Daniel P.  O'Day",
      "age": 59,
      "title": "Chairman & CEO",
      "yearBorn": 1965,
      "fiscalYear": 2024,
      "totalPay": 7137565,
      "exercisedValue": 0,
      "unexercisedValue": 30103994
    },
    {
      "maxAge": 1,
      "name": "Mr. Andrew D. Dickinson",
      "age": 54,
      "title": "Chief Financial Officer",
      "yearBorn": 1970,
      "fiscalYear": 2024,
      "totalPay": 2729705,
      "exercisedValue": 5536695,
      "unexercisedValue": 8763160
    },
    {
      "maxAge": 1,
      "name": "Ms. Deborah H. Telman J.D.",
      "age": 59,
      "title": "Executive VP of Corporate Affairs, General Counsel & Corporate Secretary",
      "yearBorn": 1965,
      "fiscalYear": 2024,
      "totalPay": 3107954,
      "exercisedValue": 0,
      "unexercisedValue": 1127163
    },
    {
      "maxAge": 1,
      "name": "Ms. Johanna  Mercier",
      "age": 54,
      "title": "Chief Commercial Officer",
      "yearBorn": 1970,
      "fiscalYear": 2024,
      "totalPay": 3169442,
      "exercisedValue": 0,
      "unexercisedValue": 12195903
    },
    {
      "maxAge": 1,
      "name": "Ms. Diane E. Wilfong",
      "age": 62,
      "title": "Interim Corporate Controller, Chief Accounting Officer & Principal Accounting Officer",
      "yearBorn": 1962,
      "fiscalYear": 2024,
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Ms. Jacquie  Ross C.F.A.",
      "title": "Senior Vice President of Treasury and Investor Relations",
      "fiscalYear": 2024,
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Ms. Jyoti K. Mehra",
      "age": 47,
      "title": "Executive Vice President of Human Resources",
      "yearBorn": 1977,
      "fiscalYear": 2024,
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Dr. Linda Slanec Higgins Ph.D.",
      "age": 62,
      "title": "Senior Vice President of Research, Innovation & Portfolio",
      "yearBorn": 1962,
      "fiscalYear": 2024,
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Dr. Flavius  Martin M.D.",
      "title": "Executive Vice President of Research",
      "fiscalYear": 2024,
      "exercisedValue": 0,
      "unexercisedValue": 0
    },
    {
      "maxAge": 1,
      "name": "Ms. Janet  Dorling",
      "age": 49,
      "title": "Senior Vice President of Intercontinental Region & Global Patient Solutions",
      "yearBorn": 1975,
      "fiscalYear": 2024,
      "exercisedValue": 0,
      "unexercisedValue": 0
    }
  ],
  "auditRisk": 9,
  "boardRisk": 5,
  "compensationRisk": 4,
  "shareHolderRightsRisk": 2,
  "overallRisk": 3,
  "governanceEpochDate": 1756684800,
  "compensationAsOfEpochDate": 1735603200,
  "irWebsite": "http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-irhome",
  "executiveTeam": [],
  "maxAge": 86400,
  "priceHint": 2,
  "previousClose": 113.76,
  "open": 113.55,
  "dayLow": 111.325,
  "dayHigh": 113.59,
  "regularMarketPreviousClose": 113.76,
  "regularMarketOpen": 113.55,
  "regularMarketDayLow": 111.325,
  "regularMarketDayHigh": 113.59,
  "dividendRate": 3.16,
  "dividendYield": 2.76,
  "exDividendDate": 1757894400,
  "payoutRatio": 0.619,
  "fiveYearAvgDividendYield": 3.91,
  "beta": 0.379,
  "trailingPE": 22.329365,
  "forwardPE": 15.146703,
  "volume": 5935003,
  "regularMarketVolume": 5935003,
  "averageVolume": 6780867,
  "averageVolume10days": 6749120,
  "averageDailyVolume10Day": 6749120,
  "bid": 112.45,
  "ask": 112.62,
  "bidSize": 4,
  "askSize": 4,
  "marketCap": 139640750080,
  "fiftyTwoWeekLow": 81.83,
  "fiftyTwoWeekHigh": 121.83,
  "priceToSalesTrailing12Months": 4.8380537,
  "fiftyDayAverage": 114.0134,
  "twoHundredDayAverage": 105.5647,
  "trailingAnnualDividendRate": 3.12,
  "trailingAnnualDividendYield": 0.027426159,
  "currency": "USD",
  "tradeable": false,
  "enterpriseValue": 160938426368,
  "profitMargins": 0.21865,
  "floatShares": 1238163997,
  "sharesOutstanding": 1240809984,
  "sharesShort": 17562109,
  "sharesShortPriorMonth": 19990775,
  "sharesShortPreviousMonthDate": 1753920000,
  "dateShortInterest": 1756425600,
  "sharesPercentSharesOut": 0.014199999,
  "heldPercentInsiders": 0.001,
  "heldPercentInstitutions": 0.90747,
  "shortRatio": 2.79,
  "shortPercentOfFloat": 0.014199999,
  "impliedSharesOutstanding": 1240809984,
  "bookValue": 15.841,
  "priceToBook": 7.1043496,
  "lastFiscalYearEnd": 1735603200,
  "nextFiscalYearEnd": 1767139200,
  "mostRecentQuarter": 1751241600,
  "earningsQuarterlyGrowth": 0.214,
  "netIncomeToCommon": 6311000064,
  "trailingEps": 5.04,
  "forwardEps": 7.43,
  "lastSplitFactor": "2:1",
  "lastSplitDate": 1359331200,
  "enterpriseToRevenue": 5.576,
  "enterpriseToEbitda": 11.661,
  "52WeekChange": 0.37746513,
  "SandP52WeekChange": 0.16885936,
  "lastDividendValue": 0.79,
  "lastDividendDate": 1749772800,
  "quoteType": "EQUITY",
  "currentPrice": 112.54,
  "targetHighPrice": 143.0,
  "targetLowPrice": 98.0,
  "targetMeanPrice": 124.7936,
  "targetMedianPrice": 128.0,
  "recommendationMean": 1.71429,
  "recommendationKey": "buy",
  "numberOfAnalystOpinions": 25,
  "totalCash": 6057999872,
  "totalCashPerShare": 4.882,
  "ebitda": 13800999936,
  "totalDebt": 24945999872,
  "quickRatio": 0.969,
  "currentRatio": 1.315,
  "totalRevenue": 28863000576,
  "debtToEquity": 127.34,
  "revenuePerShare": 23.155,
  "returnOnAssets": 0.12616,
  "returnOnEquity": 0.33403,
  "grossProfits": 22666999808,
  "freeCashflow": 8835000320,
  "operatingCashflow": 9868000256,
  "earningsGrowth": 0.209,
  "revenueGrowth": 0.018,
  "grossMargins": 0.78533,
  "ebitdaMargins": 0.47816002,
  "operatingMargins": 0.39156,
  "financialCurrency": "USD",
  "symbol": "GILD",
  "language": "en-US",
  "region": "US",
  "typeDisp": "Equity",
  "quoteSourceName": "Nasdaq Real Time Price",
  "triggerable": true,
  "customPriceAlertConfidence": "HIGH",
  "shortName": "Gilead Sciences, Inc.",
  "longName": "Gilead Sciences, Inc.",
  "earningsTimestamp": 1754596800,
  "earningsTimestampStart": 1762372800,
  "earningsTimestampEnd": 1762372800,
  "earningsCallTimestampStart": 1754598600,
  "earningsCallTimestampEnd": 1754598600,
  "isEarningsDateEstimate": true,
  "epsTrailingTwelveMonths": 5.04,
  "epsForward": 7.43,
  "epsCurrentYear": 8.09993,
  "priceEpsCurrentYear": 13.893948,
  "fiftyDayAverageChange": -1.4733963,
  "fiftyDayAverageChangePercent": -0.012923011,
  "twoHundredDayAverageChange": 6.9753036,
  "twoHundredDayAverageChangePercent": 0.0660761,
  "sourceInterval": 15,
  "exchangeDataDelayedBy": 0,
  "averageAnalystRating": "1.7 - Buy",
  "cryptoTradeable": false,
  "postMarketChangePercent": 0.0,
  "postMarketPrice": 112.54,
  "postMarketChange": 0.0,
  "regularMarketChange": -1.2200012,
  "regularMarketDayRange": "111.325 - 113.59",
  "fullExchangeName": "NasdaqGS",
  "averageDailyVolume3Month": 6780867,
  "fiftyTwoWeekLowChange": 30.71,
  "fiftyTwoWeekLowChangePercent": 0.37529022,
  "fiftyTwoWeekRange": "81.83 - 121.83",
  "fiftyTwoWeekHighChange": -9.290001,
  "fiftyTwoWeekHighChangePercent": -0.0762538,
  "fiftyTwoWeekChangePercent": 37.746513,
  "dividendDate": 1759104000,
  "messageBoardId": "finmb_29002",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EDT",
  "gmtOffSetMilliseconds": -14400000,
  "market": "us_market",
  "esgPopulated": false,
  "regularMarketChangePercent": -1.0724342,
  "regularMarketPrice": 112.54,
  "corporateActions": [
    {
      "header": "Dividend",
      "message": "GILD announced a cash dividend of 0.79 with an ex-date of Sep. 15, 2025",
      "meta": {
        "eventType": "DIVIDEND",
        "dateEpochMs": 1757908800000,
        "amount": "0.79"
      }
    }
  ],
  "postMarketTime": 1757967003,
  "regularMarketTime": 1757966401,
  "exchange": "NMS",
  "marketState": "POST",
  "hasPrePostMarketData": true,
  "firstTradeDateMilliseconds": 696090600000,
  "displayName": "Gilead Sciences",
  "trailingPegRatio": 0.2155
}